Výsledky vyhledávání - "říhová, L."

Akademický článek

JAK2V617F mutation and circulating extracellular vesicles in essential thrombocythemia.

Autor: Aswad MH; Department of Clinical Hematology, Faculty of Medicine, University Hospital Brno, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic., Kissova J; Department of Clinical Hematology, Faculty of Medicine, University Hospital Brno, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic., Ovesna P; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Říhová L; Department of Clinical Hematology, Faculty of Medicine, University Hospital Brno, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic., Penka M; Department of Clinical Hematology, Faculty of Medicine, University Hospital Brno, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Publikováno v: Clinical hemorheology and microcirculation [Clin Hemorheol Microcirc] 2023; Vol. 84 (4), pp. 359-368.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma.

Autor: Vlachová M; Babak Myeloma Group, Department of Pathophysiology, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic., Gregorová J; Babak Myeloma Group, Department of Pathophysiology, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic., Vychytilová-Faltejsková P; Babak Myeloma Group, Department of Pathophysiology, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.; Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic., Gabło NA; Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic., Radová L; Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic., Pospíšilová L; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic., Almáši M; Department of Clinical Hematology, University Hospital Brno, 625 00 Brno, Czech Republic., Štork M; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, 625 00 Brno, Czech Republic., Knechtová Z; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, 625 00 Brno, Czech Republic., Minařík J; Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, 779 00 Olomouc, Czech Republic., Popková T; Department of Hematooncology, University Hospital Ostrava, Ostrava, and Faculty of Medicine, University Ostrava, 708 00 Ostrava, Czech Republic., Jelínek T; Department of Hematooncology, University Hospital Ostrava, Ostrava, and Faculty of Medicine, University Ostrava, 708 00 Ostrava, Czech Republic., Hájek R; Department of Hematooncology, University Hospital Ostrava, Ostrava, and Faculty of Medicine, University Ostrava, 708 00 Ostrava, Czech Republic., Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, 625 00 Brno, Czech Republic., Říhová L; Department of Clinical Hematology, University Hospital Brno, 625 00 Brno, Czech Republic., Ševčíková S; Babak Myeloma Group, Department of Pathophysiology, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2022 Nov 25; Vol. 23 (23). Date of Electronic Publication: 2022 Nov 25.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine.

Autor: Zátopková M; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Biology and Ecology, University of Ostrava, Ostrava, Czech Republic., Ševčíková T; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Biology and Ecology, University of Ostrava, Ostrava, Czech Republic., Fanfani V; Institute of Quantitative Biology, Biochemistry and Biotechnology, University of Edinburgh, Edinburgh, United Kingdom., Chyra Z; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Říhová L; Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic., Bezděková R; Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic., Žihala D; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Biology and Ecology, University of Ostrava, Ostrava, Czech Republic., Growková K; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Biology and Ecology, University of Ostrava, Ostrava, Czech Republic., Filipová J; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Černá L; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Broskevičova L; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic., Kryukov F; Clinical Development Department, Joint-stock Company BIOCAD, Saint Petersburg, Russia., Minařík J; Department of Hematooncology, University Hospital and Palacky University Olomouc, Olomouc, Czech Republic., Smejkalová J; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic., Maisnar V; 4th Department of Medicine-Haematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic., Harvanová Ĺ; Department of Hematology and Transfusiology, University Hospital Bratislava, Bratislava, Slovakia., Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic; and., Jungova A; Department of Hemato-Oncology, Charles University Hospital Pilsen, Pilsen, Czech Republic., Popková T; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic., Bago JR; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic., Anilkumar Sithara A; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic., Hrdinka M; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic., Jelínek T; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Biology and Ecology, University of Ostrava, Ostrava, Czech Republic., Šimíček M; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Biology and Ecology, University of Ostrava, Ostrava, Czech Republic., Stracquadanio G; Institute of Quantitative Biology, Biochemistry and Biotechnology, University of Edinburgh, Edinburgh, United Kingdom., Hájek R; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.

Publikováno v: Blood advances [Blood Adv] 2022 Jan 25; Vol. 6 (2), pp. 368-372.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání